Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Participants Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending d…
Type 1 Diabetes MellitusT1DT1DM+7 more
Estimated
~$10 – $8,750
COUR Pharmaceutical Development Company, Inc.NCT06783309
Observational
Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)
Bolus Priming (BP) based on Artificial Intelligence (AI) learning of meal patterns, added to our established Automated insulin delivery as Adaptive Network (AI…
Type 1 Diabetes Mellitis
Estimated
~$10 – $7,500
Sue BrownNCT07517770